Cardiovascular Disease

Showing NaN - NaN of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy

Enrolling by invitation
  • Hypercholesterolemia
  • +7 more
  • Modified Atkins or Ketogenic Diet
  • Baltimore, Maryland
    Johns Hopkins University
Jan 6, 2023

Patients With Heart Failure Using HeartLogic

Completed
  • Heart Failure
  • +5 more
  • HeartLogic Sensors
  • Birmingham, Alabama
  • +87 more
Oct 24, 2022

Healthy Aging in Neighborhoods of Diversity Across Life Span

Active, not recruiting
  • Diabetes
  • +3 more
    • Baltimore, Maryland
      National Institute of Aging, Clinical Research Unit
    Aug 24, 2022

    Cardiovascular Disease, Hypertension, Care Coordination Trial in United States (Intervention group, Education control group)

    Recruiting
    • Cardiovascular Disease
    • +3 more
    • Intervention group
    • Education control group
    • Decatur, Georgia
    • +3 more
    Jul 29, 2022

    Aging, Exercise, Cardiovascular Disease Trial in Baltimore (Exercise Training, Exercise Cessation)

    Active, not recruiting
    • Aging
    • +2 more
    • Exercise Training
    • Exercise Cessation
    • Baltimore, Maryland
      University of Maryland, Baltimore & Baltimore VA Medical Center
    Feb 28, 2022

    Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

    Completed
    • Heart Failure
    • +4 more
    • Darbepoetin alfa
    • Placebo
    • Birmingham, Alabama
    • +753 more
    Oct 31, 2021

    Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)

    Completed
    • Elevated Lipoprotein(a)
    • Cardiovascular Disease
    • ISIS 681257
    • Placebo
    • Cottonwood, Arizona
    • +31 more
    Oct 26, 2020

    Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)

    Completed
    • Cardiovascular Disease
    • Birmingham, Alabama
    • +469 more
    Jul 23, 2020

    Vascular Aging: The Link That Bridges Age to Atherosclerosis

    Terminated
    • Atherosclerosis
    • +2 more
      • Baltimore, Maryland
      • +1 more
      Dec 6, 2019

      Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

      Completed
      • Cardiovascular Disease
      • +4 more
      • Lorcaserin hydrochloride
      • Placebo
      • Alexander City, Alabama
      • +498 more
      Jun 27, 2019

      Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

      Terminated
      • Cardiovascular Disease
      • bococizumab (PF-04950615)
      • Placebo
      • Athens, Alabama
      • +1595 more
      Apr 18, 2019

      Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

      Terminated
      • Cardiovascular Disease
      • bococizumab (PF-04950615)
      • Placebo
      • Athens, Alabama
      • +1745 more
      Jun 14, 2018

      Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)

      Completed
      • Cardiovascular Disease
      • Decatur, Georgia
      • +202 more
      Jun 12, 2018

      Atherosclerosis, Cardiovascular Disease Trial in Baltimore (any statin, niacin, Placebo)

      Completed
      • Atherosclerosis
      • Cardiovascular Disease
      • any statin
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins Unversity School of Medicine
      Oct 4, 2017

      Chronic Kidney Disease, Cardiovascular Disease, Death Trial in Brazil, Canada, United States (High Dose Multivitamin, Low Dose

      Completed
      • Chronic Kidney Disease
      • +2 more
      • High Dose Multivitamin
      • Low Dose Multivitamin
      • Birmingham, Alabama
      • +29 more
      Sep 17, 2017

      Cardiovascular Disease Trial in Worldwide (EVARREST™ Fibrin Sealant Patch, Topical hemostat)

      Completed
      • Cardiovascular Disease
      • EVARREST™ Fibrin Sealant Patch
      • Topical hemostat
      • Atlanta, Georgia
      • +23 more
      Aug 14, 2017

      Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

      Terminated
      • Type 2 Diabetes
      • Cardiovascular Disease
      • Birmingham, Alabama
      • +587 more
      Oct 15, 2015

      Cardiovascular Disease Trial in Baltimore (Aspirin, Durlaza™)

      Completed
      • Cardiovascular Disease
      • Baltimore, Maryland
        Platelet and Thrombosis Research, LLC
      Aug 4, 2015

      Diabetes, Cardiovascular Disease, Substance Abuse Disorder Trial in Baltimore (Co-developed IT intervention)

      Unknown status
      • Diabetes
      • +3 more
      • Co-developed IT intervention
      • Baltimore, Maryland
        Zip codes surrounding Johns Hopkins Hospital
      Aug 20, 2014

      Physician Utilization of Shock Reduction Programming

      Completed
      • Cardiovascular Disease
      • Therapy Programming Report (TPR)
      • Anniston, Alabama
      • +103 more
      Jul 1, 2014

      Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)

      Terminated
      • Type 2 Diabetes Mellitus
      • Cardiovascular Disease
      • Birmingham, Alabama
      • +777 more
      Apr 1, 2014

      Cardiovascular Disease, Stable Angina, Myocardial Infarction Trial in Baltimore (ticagrelor)

      Unknown status
      • Cardiovascular Disease
      • +3 more
      • Baltimore, Maryland
        Sinai Center for Thrombosis Research
      Dec 10, 2013

      Type 2 Diabetes, Cardiovascular Disease, Hypertension Trial in Worldwide (Dapagliflozin, Placebo)

      Completed
      • Type 2 Diabetes Mellitus
      • +3 more
      • Gulf Shores, Alabama
      • +140 more
      Sep 24, 2013

      Cardiovascular Disease, Obstructive Sleep Apnea, Coronary Artery Disease Trial in Baltimore, Boston, Cleveland (Healthy

      Completed
      • Cardiovascular Disease
      • +2 more
      • Healthy Lifestyles and Sleep Education plus PAP
      • +2 more
      • Baltimore, Maryland
      • +3 more
      Feb 21, 2013

      Cardiovascular Disease Trial in Baltimore (Placebo, Doxycycline)

      Withdrawn
      • Cardiovascular Disease
      • Baltimore, Maryland
        Johns Hopkins University SOM. 1830 East Monument St, Ste 7500
      Mar 29, 2012